Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease-Reference-Cited by-同舟云学术

Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease

Published:2023-12-26 Issue:4 Volume:63 Page:246-250
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Kobayashi Hiroki¹,Ouchi Tomoki¹,Kitamura Wataru²,Asakura Shoji³,Yano Tomofumi³,Takeda Hiromasa¹,Tokuda Yoshiyuki¹,Yoshino Tadashi⁴,Maeda Yoshinobu⁵

Affiliation:

1. Department of Internal Medicine, Tsuyama Chuo Hospital, Okayama, Japan,

2. Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan,

3. Department of Internal Medicine, Okayama Rosai Hospital, Okayama, Japan,

4. Department of Pathology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan,

5. Department of Hematology, Oncology, and Respiratory Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/63/4/63_23040/_pdf

Reference20 articles.

1. 1 Röth A, Fryzek J, Jiang X et al. Complement‐mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion. 2022; 62: 51-59.

2. 2 Campo E, Jaffe ES, Cook JR et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022; 140: 1229-1253.

3. 3 Chapin J, Terry HS, Kleinert D, Laurence J. The role of complement activation in thrombosis and hemolytic anemias. Transfus Apher Sci. 2016; 54: 191-198.

4. 4 Polack FP, Thomas SJ, Kitchin N et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383: 2603-2615.

5. 5 Baden LR, El Sahly HM, Essink B et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021; 384: 403-416.